Robert Shafer, MD
Enriched profileProfessor (Research) of Medicine (Infectious Diseases and Geographic Medicine) and, by courtesy, of Pathology · Stanford University School of Medicine
Robert Shafer is Professor (Research) of Medicine (Infectious Diseases and Geographic Medicine) and, by courtesy, of Pathology at Stanford University School of Medicine. OpenAlex indexes 377 publications with 25,467 citations (h-index 86); ClinicalTrials.gov lists 2 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 5% of Infectious Disease profiles in the findmyKOL directory.
Data verified 14 Aug 2026
Overview
Updated 15 Oct 2026
Robert Shafer, MD, is Professor (Research) of Medicine (Infectious Diseases and Geographic Medicine) and, by courtesy, of Pathology at Stanford University School of Medicine, Department of Medicine - Infectious Diseases and Geographic Medicine. The public record shows 377 publications with 25,467 citations (h-index 86), centered on HIV/AIDS drug development and treatment, HIV Research and Treatment, HIV/AIDS Research and Interventions. It also documents an investigator role on 2 registered clinical trials, industry payments reported by 3 companies, 7 NIH-funded awards (1999–2026).
- Most recent indexed publication: 2026 · PloS one
- Top research focus: HIV/AIDS drug development and treatment
- 2 registered trials on ClinicalTrials.gov
- Open Payments reporting from 3 companies
Generated from the cited public record · current as of 15 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 24 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 249.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 15 Oct 2026
Listed as an investigator on 2 registered studies on ClinicalTrials.gov. The most recent:
- Maraviroc as an Immunomodulatory Drug for Antiretroviral-treated HIV Infected Patients Exhibiting Immunologic Failure
Sponsor: University of California, San Francisco
- A Study to Evaluate Various Combinations of Anti-HIV Medications to Treat Early HIV Infection
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Industry payments
Updated 15 Oct 2026
3 companies reported payments to CMS in program years 2021–2023. These are public disclosures, not judgments. The latest:
- ViiV Healthcare CompanyProgram year20231 payment
- GlaxoSmithKline, LLC.Program year20221 payment
- GlaxoSmithKline, LLC.Program year20212 payments
NIH funding
Updated 15 Oct 2026
7 NIH research awards on record, funded 1999–2026 per NIH RePORTER. The latest:
Publications
Updated 15 Oct 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Genotypic challenges in implementing broadly neutralizing antibody-based long-acting HIV-1 therapies.
Communications medicine
Review2026 - Emergent HIV-1 Drug Resistance in Randomized Trials of Contemporary Antiretroviral Regimens.
Clinical infectious diseases
Review2026
Most-cited works
by citation count (OpenAlex)Network
Updated 15 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 15 Oct 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/robert-shafer-md-f8a3a8a3
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - ResearchGate
researchgate.net/profile/Robert-Shafer
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →researchgate.net ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 15 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.stanford.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.stanford.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.stanford.edu ↗
Editorial & leadership roles
journal and society appointments- Faculty member
IAS-USA (International Antiviral Society-USA) HIV drug resistance education program
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →iasusa.org ↗ - Principal investigator / director
Stanford HIV Drug Resistance Database (HIVDB.stanford.edu), a public resource for HIV drug resistance surveillance and genotypic test interpretation
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.stanford.edu ↗ - Technical director
Stanford University Hospitals Genotypic Antiretroviral Resistance Program
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.stanford.edu ↗
Secondary affiliations
appointments beyond the home institution- By-courtesy appointment
Department of Pathology, Stanford University
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.stanford.edu ↗ - Member
Bio-X (Stanford interdisciplinary research institute)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →biox.stanford.edu ↗ - Clinical practice
Stanford Health Care (Infectious Diseases)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →stanfordhealthcare.org ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Paul Heidenreich, MD
Stanford University School of Medicine
Alan Schatzberg, MD
Stanford University School of Medicine
Euan Ashley, MD
Stanford University School of Medicine
Mark Pegram, MD
Stanford University School of Medicine
Yousef Khader
Jordan University of Science and Technology
Thomas Walsh, MD
Cornell University
Vance Fowler, MD
Duke University
Derrick W. Crook
Nuffield Orthopaedic Centre